Previous 10 | Next 10 |
VolitionRx Limited (VNRX) Q1 2022 Results Conference Call May 12, 2022 08:30 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Tom Butera - Chief Executive Officer, Volition Veterinary Diagnostics ...
The following slide deck was published by VolitionRx Limited in conjunction with their 2022 Q1 earnings call. For further details see: VolitionRx Limited 2022 Q1 - Results - Earnings Call Presentation
VolitionRX press release (NYSE:VNRX): Q1 net loss of $7.7M Cash and cash equivalents as of March 31, 2022, totaled approximately $23.7 million compared with $20.6 million as of December 31, 2021. For further details see: VolitionRX reports Q1 results
VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update PR Newswire Conference call to discuss financial and operational results scheduled for Thursday, May 12 , at 8:30 a.m. U.S. Eastern Time AUSTIN, Texas , May 11...
VolitionRX (NYSE:VNRX) Q1 consensus EPS estimate is $0.04 and consensus revenue estimate is $10.02M. VNRX is scheduled to announce Q1 earnings results on Thursday, May 12, before market open. Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward revis...
ACOR, ADMA, APP, ASM, ASND, ASYS, ATCO, BAK, BMBL, BROS, BYND, CLPT, CLSD, CPA, CPNG, CYCC, DIS, DOX, ENVX, FLNC, FOSL, FSM, GAIN, GBDC, ICAD, KGC, LGO, LKCO, LTBR, MBII, METC, MFC, MQ, MRAM, MYO, NEON, NOAH, OCX, ONTX, OR, OTRK, PAAS, PAYS, PSTL, OTCPK:PWCDF, RIVN, SAND, SCM, SCTL, SLF, SMTS...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
VolitionRx Limited Schedules First Quarter 2022 Earnings Conference Call and Business Update PR Newswire Conference call to take place on Thursday May 12 at 08:30 a.m. Eastern Time Capital Markets Day Friday May 13 at 10:00 a.m. Eastern Time ...
VolitionRx Limited to Host Capital Markets Day on Friday May 13 PR Newswire AUSTIN, Texas , May 5, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") a multi-national epigenetics company plans to host a Capital Markets Day in ...
Volition (VNRX) formal corporate presentation from NobleCon18 - Noble Capital Markets 18th Annual Small & Microcap Investor Conference - April 2022. Read More >>
News, Short Squeeze, Breakout and More Instantly...
VolitionRx Limited (NYSE American: VNRX) , a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, announced the engagement of PharmaVentures Ltd (“PharmaVentures”) to act as an advisor. PharmaVentures w...
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing PR Newswire HENDERSON, Nev. , July 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed PharmaV...
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...